Skip Navigation

European Heart Journal 1990 11(7):583-591;
Copyright © 1990 by the European Society of Cardiology.
This Article
Right arrow Full Text (PDF)
Right arrow Alert me when this article is cited
Right arrow Alert me if a correction is posted
Services
Right arrow Email this article to a friend
Right arrow Similar articles in this journal
Right arrow Similar articles in PubMed
Right arrow Alert me to new issues of the journal
Right arrow Add to My Personal Archive
Right arrow Download to citation manager
Right arrowRequest Permissions
Google Scholar
Right arrow Articles by VOGT, S.
Right arrow Articles by BURCKHARDT, D.
Right arrow Search for Related Content
PubMed
Right arrow PubMed Citation
Right arrow Articles by VOGT, S.
Right arrow Articles by BURCKHARDT, D.
Social Bookmarking
 Add to CiteULike   Add to Connotea   Add to Del.icio.us  
What's this?

© 1990 The European Society of Cardiology

Heart valve replacement with the Björk-Shiley and St Jude Medical prostheses: A randomized comparison in 178 patients

S. VOGT, A. HOFFMANN, J. ROTH, P. DUBACH, W. BERTSCHMANN, J. HASSE, E. GRÄDEL, P. STULZ and D. BURCKHARDT

Division of Cardiology, Department of Internal Medicine and Division of Cardiac and Thoracic Surgery, Department of Surgery, University Hospital Basel Switzerland

Received 4 July 1989; revised 2 October 1989; .

Correspondence address: Prof. D. Burckhardt M.D., Division of Cardiology, Department of Internal Medicine, University Hospital, CH-4031 Basel/Switzerland.

Abstract

In 178 patients, a randomized prospective comparison between the 60° spherical disc Björk-Shiley (BS) and the St Jude Medical (SJM) heart valve prostheses was performed. Four-week perioperative mortality was zero in the BS (n = 84) and 4.3% in the SJM group (n = 94). During a mean ( ± SD) follow-up of 52 ± 20 months or 778 patient-years, late cardiac mortality per year was 2.4% in the BS and 2.2% in the SJM group. The yearly thromboembolic rates were 1.4% in the BS and 2.0% in the SJM group. There was no mechanical valve failure or haemolytic anaemia. Paravalvular leaks and major bleeding complications occurred at low rates in both groups (1.1% and2.2% per year in BS; 0.7% and 1.7% per year in SJM). Functional results were similarly good with 96% of patients with BS valves and 95% of patients with SJM prostheses being in NYHA classes I and II, respectively.

We conclude that heart valve replacement with mechanical prostheses can be performed with equally good results using either the Björk-Shiley spherical disc valve or the St Jude Medical bileaflet prosthesis.

Key Words: Valve replacement • St Jude Medical prosthesis • Björk-Shiley prosthesis • randomized comparison • prosthetic heart valve


Add to CiteULike CiteULike   Add to Connotea Connotea   Add to Del.icio.us Del.icio.us    What's this?


This article has been cited by other articles:


Home page
J Am Coll CardiolHome page
R. O. Bonow, B. A. Carabello, K. Chatterjee, A. C. de Leon Jr, D. P. Faxon, M. D. Freed, W. H. Gaasch, B. W. Lytle, R. A. Nishimura, P. T. O'Gara, et al.
ACC/AHA 2006 Guidelines for the Management of Patients With Valvular Heart Disease: A Report of the American College of Cardiology/American Heart Association Task Force on Practice Guidelines (Writing Committee to Revise the 1998 Guidelines for the Management of Patients With Valvular Heart Disease) Developed in Collaboration With the Society of Cardiovascular Anesthesiologists Endorsed by the Society for Cardiovascular Angiography and Interventions and the Society of Thoracic Surgeons
J. Am. Coll. Cardiol., August 1, 2006; 48(3): e1 - e148.
[Full Text] [PDF]


Home page
ChestHome page
D. N. Salem, P. D. Stein, A. Al-Ahmad, H. I. Bussey, D. Horstkotte, N. Miller, and S. G. Pauker
Antithrombotic Therapy in Valvular Heart Disease--Native and Prosthetic: The Seventh ACCP Conference on Antithrombotic and Thrombolytic Therapy
Chest, September 1, 2004; 126(3_suppl): 457S - 482S.
[Abstract] [Full Text] [PDF]


Home page
J. Thorac. Cardiovasc. Surg.Home page
Y. Wu, R. Gregorio, A. Renzulli, F. Onorati, M. De Feo, G. Grunkemeier, and M. Cotrufo
Mechanical heart valves: Are two leaflets better than one?
J. Thorac. Cardiovasc. Surg., April 1, 2004; 127(4): 1171 - 1179.
[Abstract] [Full Text] [PDF]


Home page
ChestHome page
P. D. Stein, J. S. Alpert, H. I. Bussey, J. E. Dalen, and A. G.G. Turpie
Antithrombotic Therapy in Patients With Mechanical and Biological Prosthetic Heart Valves
Chest, January 1, 2001; 119(1_suppl): 220S - 227S.
[Full Text] [PDF]


Home page
Ann. Thorac. Surg.Home page
C. E.E. Kuntze, E. H. Blackstone, and T. Ebels
Thromboembolism and mechanical heart valves: a randomized study revisited
Ann. Thorac. Surg., July 1, 1998; 66(1): 101 - 107.
[Abstract] [Full Text] [PDF]


Home page
J. Thorac. Cardiovasc. Surg.Home page
L-F. Debetaz, P. Ruchat, M. Hurni, A. Fischer, F. Stumpe, H. Sadeghi, G. van Melle, and J-J. Goy
ST. JUDE MEDICAL VALVE PROSTHESIS: AN ANALYSIS OF LONG-TERM OUTCOME AND PROGNOSTIC FACTORS
J. Thorac. Cardiovasc. Surg., January 1, 1997; 113(1): 134 - 148.
[Abstract] [Full Text]


Home page
NEJMHome page
M. H. Eckman, H. J. Levine, and S. G. Pauker
Effect of Laboratory Variation in the Prothrombin-Time Ratio on the Results of Oral Anticoagulant Therapy
N. Engl. J. Med., September 2, 1993; 329(10): 696 - 702.
[Abstract] [Full Text]


Home page
NEJMHome page
K. E. Hammermeister, G. K. Sethi, W. G. Henderson, C. Oprian, T. Kim, S. Rahimtoola, and The Veterans Affairs Cooperative Study on Valvular
A Comparison of Outcomes in Men 11 Years after Heart-Valve Replacement with a Mechanical Valve or Bioprosthesis
N. Engl. J. Med., May 6, 1993; 328(18): 1289 - 1296.
[Abstract] [Full Text]



Disclaimer:
Please note that abstracts for content published before 1996 were created through digital scanning and may therefore not exactly replicate the text of the original print issues. All efforts have been made to ensure accuracy, but the Publisher will not be held responsible for any remaining inaccuracies. If you require any further clarification, please contact our Customer Services Department.